Roberto Pili
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma (NCT03552380) | Roberto Pili | 2018-07-31 |
| High Dose IL 2 and Entinostat in RCC (NCT03501381) | Roberto Pili | 2018-05-24 |
Track Roberto Pili automatically
Every clearance here is in the API, with alerts when new ones post.